AA Pharma Consultancy Limited - Accounts to registrar (filleted) - small 18.2

AA Pharma Consultancy Limited - Accounts to registrar (filleted) - small 18.2


IRIS Accounts Production v18.3.0.592 07677961 director 1.7.17 30.6.18 30.6.18 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure076779612017-06-30076779612018-06-30076779612017-07-012018-06-30076779612016-06-30076779612016-07-012017-06-30076779612017-06-3007677961ns15:EnglandWales2017-07-012018-06-3007677961ns14:PoundSterling2017-07-012018-06-3007677961ns10:Director12017-07-012018-06-3007677961ns10:PrivateLimitedCompanyLtd2017-07-012018-06-3007677961ns10:SmallEntities2017-07-012018-06-3007677961ns10:AuditExemptWithAccountantsReport2017-07-012018-06-3007677961ns10:SmallCompaniesRegimeForDirectorsReport2017-07-012018-06-3007677961ns10:SmallCompaniesRegimeForAccounts2017-07-012018-06-3007677961ns10:FullAccounts2017-07-012018-06-3007677961ns10:RegisteredOffice2017-07-012018-06-3007677961ns5:CurrentFinancialInstruments2018-06-3007677961ns5:CurrentFinancialInstruments2017-06-3007677961ns5:ShareCapital2018-06-3007677961ns5:ShareCapital2017-06-3007677961ns5:RetainedEarningsAccumulatedLosses2018-06-3007677961ns5:RetainedEarningsAccumulatedLosses2017-06-30


REGISTERED NUMBER: 07677961 (England and Wales)









UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 JUNE 2018

FOR

AA PHARMA CONSULTANCY LIMITED

AA PHARMA CONSULTANCY LIMITED (REGISTERED NUMBER: 07677961)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2018




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3

Chartered Accountants' Report 4

AA PHARMA CONSULTANCY LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 30 JUNE 2018







DIRECTOR: Miss M F Jones





REGISTERED OFFICE: The Old Post Office
Nuffield
Henley- on-Thames
Oxfordshire
RG9 5SS





REGISTERED NUMBER: 07677961 (England and Wales)





ACCOUNTANTS: T J Loughnane Limited
The Studio
Broad Street Walk
Wokingham
Berkshire
RG40 1BW

AA PHARMA CONSULTANCY LIMITED (REGISTERED NUMBER: 07677961)

BALANCE SHEET
30 JUNE 2018

30.6.18 30.6.17
Notes £    £   
CURRENT ASSETS
Debtors 3 1,950 1,950

CREDITORS
Amounts falling due within one year 4 1,546 1,546
NET CURRENT ASSETS 404 404
TOTAL ASSETS LESS CURRENT
LIABILITIES

404

404

CAPITAL AND RESERVES
Called up share capital 1 1
Retained earnings 403 403
SHAREHOLDERS' FUNDS 404 404

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 June 2018.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 June 2018 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies
Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director on 13 March 2019 and were signed by:





Miss M F Jones - Director


AA PHARMA CONSULTANCY LIMITED (REGISTERED NUMBER: 07677961)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2018

1. STATUTORY INFORMATION

AA Pharma Consultancy Limited is a private company, limited by shares , registered in England and Wales. The
company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A "Small Entities" of Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to
the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or
substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance
sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from
those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that
have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the
timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they
will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.6.18 30.6.17
£    £   
Other debtors 1,950 1,950

4. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.6.18 30.6.17
£    £   
Bank loans and overdrafts 10 10
Directors' current accounts 1,536 1,536
1,546 1,546

5. ULTIMATE CONTROLLING PARTY

The controlling party is Miss M F Jones.

CHARTERED ACCOUNTANTS' REPORT TO THE DIRECTOR
ON THE UNAUDITED FINANCIAL STATEMENTS OF
AA PHARMA CONSULTANCY LIMITED

The following reproduces the text of the report prepared for the director in respect of the company's annual
unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file
a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the
Report of the Director are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the
financial statements of AA Pharma Consultancy Limited for the year ended 30 June 2018 which comprise the Income
Statement, Balance Sheet and the related notes from the company's accounting records and from information and
explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the director of AA Pharma Consultancy Limited in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of AA Pharma Consultancy Limited and state those matters that we have agreed to state to the director of AA Pharma Consultancy Limited in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than AA Pharma Consultancy Limited and its director for our work or for this report.

It is your duty to ensure that AA Pharma Consultancy Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of AA Pharma Consultancy Limited. You consider that AA Pharma Consultancy Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of AA Pharma Consultancy Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.






T J Loughnane Limited
The Studio
Broad Street Walk
Wokingham
Berkshire
RG40 1BW


13 March 2019